# A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery

> **NCT02656472** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 22 (actual)

## Conditions studied

- Pediatric Cardiac Surgery
- Complication of Extracorporeal Circulation

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Epsilon Aminocaproic Acid

## Key facts

- **NCT ID:** NCT02656472
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656472, "A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02656472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*